Los Angeles, CA, November 19 -- In a remarkable medical breakthrough, a team of researchers from the Stanford University, Calif., claim to have developed a drug which increases the levels of norepinephrine, a message-carrying chemical in the brain, thus easing the learning difficulties caused by Down’s syndrome, a chromosomal disorder which affects 5,000 newborns in the United States each year.
Recent comments
2 min 13 sec ago
1 hour 46 min ago
2 hours 18 min ago
2 hours 32 min ago
3 hours 45 min ago
6 hours 29 min ago
7 hours 22 min ago
9 hours 20 min ago
9 hours 42 min ago
12 hours 1 min ago